Allegra Medical Technologies Limited (AMT)の価格はいくらですか

Allegra Medical Technologies Limited (AMT)の価格は$0.02045326です

Allegra Medical Technologies Limited (AMT)の時価総額は何ですか

Allegra Medical Technologies Limited (AMT)の時価総額は$2.45Mです

Allegra Medical Technologies Limited (AMT) の利益

Allegra Medical Technologies Limited, established in Lane Cove West, Australia, in 1994 (and known as Advanced Surgical Design & Manufacture Limited until its name change in November 2014), is a company focused on the design, sales, and distribution of medical devices throughout Australia and New Zealand. Its operations are segmented into an Orthopedics Division and an Innovation Division. The company offers a comprehensive range of orthopedic products, addressing various anatomical needs. For the upper body, this includes fixation systems for both adult and adolescent clavicles, as well as a selection of symmetrical and asymmetrical offsets for shoulder procedures. Solutions for the hand and wrist comprise advanced offerings like StripEase, distal radius systems, compression screws, hand fracture systems, ulna shortening plates, and modular ceramic or CoCr heads. In the realm of joint replacement and reconstruction, Allegra provides an array of hip-related products such as reconstruction prostheses, modular tumor and revision systems, partial pelvis replacements, various standard and revision stems (both cementless and cemented), and diverse acetabular cup systems, including ceramic and CoCrMo prosthesis heads. For the knee, their portfolio features the ActiveKnee total knee replacement prosthesis and its accompanying surgical instruments. Foot and ankle solutions encompass total ankle replacement systems, DF toe, A-curve handles, screws, activ fuse, and plating systems. Beyond these specialized implants, the company also supplies general surgical consumables like sawblades, kirschner wires, and pins. Additionally, Allegra offers innovative solutions such as NanoFx for microfracture procedures and a variety of instrument sets tailored for different surgical requirements, including post-surgery rehabilitation, shoulder surgery, direct anterior approach, PCL protection, and revision surgery.

年	利益	変化
提供された日付のデータは十分ではありません。

年

利益

変化

提供された日付のデータは十分ではありません。

企業	利益	利益の差	国
Abbott Laboratories ABT.US	$7.51B	-	US
Stryker Corporation SYK.US	$5.15B	-	US
Medtronic plc MDT.US	$5.56B	-	IE
Boston Scientific Corporation BSX.US	$3.86B	-	US
Edwards Lifesciences Corporation EW.US	$1.42B	-	US

企業

利益

利益の差

国